NL
NL · NL · NL-abc1aada9046
Briumvi 150 mg concentraat voor oplossing voor infusie
ATC L04AG14
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerNeuraxpharm Pharmaceuticals S.L.
CountryNL (NL)
ATC codeL04AG14
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/23/1730
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/briumvi-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ublituximab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129295",
"excipients": [
"NATRIUMCHLORIDE",
"POLYSORBAAT 80 (E 433)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"UBLITUXIMAB"
],
"leaflet_url": null,
"authorised_at": "2023/05/31",
"procedure_number": "EMEA/H/C/005914",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/23/1730",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code L04AG14.
- ISBriumviNeuraxpharm Pharmaceuticals S.L.
- DKBriumviNeuraxpharm Pharmaceuticals S.L.
- 🇨🇭Briumvi
- PLBriumviNeuraxpharm Pharmaceuticals, S.L.
- 🇨🇭BriumviNeuraxpharm Switzerland AG
- NOBriumviNeuraxpharm Pharmaceuticals, S.L.
- FIBriumviNeuraxpharm Pharmaceuticals S.L.
- CZBRIUMVINeuraxpharm Pharmaceuticals, S.L., Barcelona
Access this data programmatically
Query Briumvi 150 mg concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.